Contraline Funding
Contraline is active in the following markets / industries: biotechnology and medical devices. The company has secured funding across 3 rounds and is valued at $0. Their most recent funding was raised on November 11, 2022.
Investors of Contraline
Pathfinder
Pathfinder (formerly FF Angel) is the early stage investment portfolio for Founder's Fund
Producer/financier of Film and TV and digital media
Angel investor
Founder of 1821 Studios Canada, 1821 Pictures, Rhea Films, Realize Tech Fund
Mark Galant
Looking to invest in sustainable business models with moat.
Investor, Thinker, Philanthropist
Founder and Chairman:
Cal Beh Sol inc
Bilma Properties Inc
Co-Founder and CEO of Quantitative Investment Management, $3B hedge fund manager. I program all the statistical prediction models that drive all investments.
Rounds
S
Partner @Kima Ventures - Former Partner @The Family Here is my Investment Thesis: http://bit.ly/1x5nk1t
Philippe Sommer
Founder, CvilleTrep, LLC
Retired Director, iLab & Incubator/Batten Institute, University of Virginia
Rounds
S
Tydall Investment Partners
Rounds
S
Y combinator created a new model for funding early stage startups